Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
CC transcript
Inv. presentation
ISTA PHARMACEUTICALS INC (ISTA) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/06/2012 8-K Quarterly results
06/05/2012 8-K Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits
Docs: "Press Release of ISTA Pharmaceuticals, Inc."
05/04/2012 8-K Quarterly results
Docs: "ISTA Pharmaceuticals Reports First Quarter 2012 Financial Results"
04/24/2012 8-K Other Events, Financial Statements and Exhibits
Docs: "Bausch + Lomb and ISTA Pharmaceuticals Announce Early Termination of Hart-Scott-Rodino Waiting Period"
04/17/2012 8-K Other Events, Financial Statements and Exhibits
Docs: "Text of E-Mail to Employees"
02/23/2012 8-K Form 8-K - Current report
02/17/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/17/2012 8-K Form 8-K - Current report
01/04/2012 8-K Investor presentation
Docs: "ISTA Pharmaceuticals Announces Preliminary 2011 Revenue Results; Provides 2012 Financial Guidance and Updates Key Pipeline Milestones • Expects Profitability in 2011 for the Second Consecutive Year on an Adjusted Cash Net Income Basis • Unaudited 2011 Net Revenues Expected to be Greater than $160 Million • 2012 Net Revenues Expected to Grow to between $180 Million and $195 Million",
"2012 Guidance and Pipeline Update Presentation - January 2012"
12/06/2011 8-K Form 8-K - Current report
11/04/2011 8-K Form 8-K - Current report
10/18/2011 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Investor Presentation Slide Deck"
08/08/2011 8-K Form 8-K - Current report
05/16/2011 8-K Form 8-K - Current report
05/04/2011 8-K Quarterly results
Docs: "ISTA Pharmaceuticals Reports First Quarter 2011 Financial Results - Revenues Increased 30% Over Prior Year Quarter to $36.7 Million - - ISTA Reaffirms 2011 Guidance, Adds Adjusted Cash Net Income and EPS Estimate - - Announces Initiation of Low-Concentration BROMDAY Phase 3 Studies -"
04/14/2011 8-K Form 8-K - Current report
02/23/2011 8-K Form 8-K - Current report
02/10/2011 8-K Form 8-K - Current report
01/06/2011 8-K Form 8-K - Current report
12/21/2010 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Loan Modification Agreement, by and between ISTA Pharmaceuticals, Inc. and Silicon Valley Bank"
12/09/2010 8-K Submission of Matters to a Vote of Security Holders
11/02/2010 8-K Form 8-K - Current report
10/18/2010 8-K Form 8-K - Current report
08/31/2010 8-K Form 8-K - Current report
08/04/2010 8-K Form 8-K - Current report
06/30/2010 8-K Other Events
04/30/2010 8-K Quarterly results
Docs: "ISTA Pharmaceuticals Reports First Quarter 2010 Financial Results - Revenues Increased 39% Over Prior Year Quarter to $28.3 Million - - ISTA Reaffirms 2010 Guidance, Aims for First Year of Profitability -"
03/18/2010 8-K Form 8-K - Current report
02/23/2010 8-K Form 8-K - Current report
02/09/2010 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "ISTA Pharmaceuticals Announces 2010 Financial Guidance ISTA Expects 2010 Net Revenue of $147 to $165 Million Company Anticipates 2010 Operating Income of $8 to $10 Million"
02/08/2010 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "ISTA Pharmaceuticals Announces Preliminary, Unaudited Revenue of $110.6 Million in 2009 - 2010 Guidance Will Be Announced on February 9, 2010 - - Full 2009 Financial Results Will Be Announced on February 23, 2010 -"
02/05/2010 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
12/17/2009 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Letter Agreement, by and between Senju Pharmaceutical Co., Ltd and ISTA Pharmaceuticals, Inc",
"Letter Agreement, by and between Senju Pharmaceutical Co., Ltd and ISTA Pharmaceuticals, Inc",
"Loan Modification Agreement, by and between ISTA Pharmaceuticals, Inc. and Silicon Valley Bank"
12/11/2009 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "2009 Employee Stock Purchase Plan",
"Fourth Amendment and Restatement of the 2004 Performance Incentive Plan"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy